Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $888.23 | 61 | 99.4% |
| Education | $5.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $182.32 | 11 | $0 (2017) |
| Lilly USA, LLC | $142.22 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.72 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $123.15 | 16 | $0 (2017) |
| Novo Nordisk Inc | $80.05 | 6 | $0 (2017) |
| PFIZER INC. | $46.85 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $41.02 | 3 | $0 (2017) |
| Tactile Systems Technology Inc | $28.67 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $18.54 | 1 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $17.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.51 | 2 | Lilly USA, LLC ($18.90) |
| 2023 | $46.04 | 3 | Novartis Pharmaceuticals Corporation ($18.54) |
| 2022 | $124.72 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($124.72) |
| 2017 | $684.96 | 56 | AstraZeneca Pharmaceuticals LP ($182.32) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes | ||||||
| 05/31/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Oncology | ||||||
| 05/04/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Allergy/Immunology | ||||||
| 02/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Respiratory | ||||||
| 10/03/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/29/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/28/2017 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/26/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 09/20/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Respiratory | ||||||
| 09/18/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Diabetes | ||||||
| 09/14/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Respiratory | ||||||
| 09/11/2017 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/11/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Diabetes | ||||||
| 08/30/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $12.67 | General |
| 08/28/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 08/24/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 08/10/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 215 | 303 | $31,733 | $20,496 |
| 2022 | 4 | 157 | 168 | $32,922 | $11,863 |
| 2021 | 9 | 548 | 645 | $105,340 | $44,870 |
| 2020 | 9 | 414 | 512 | $87,047 | $30,279 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 190 | $18,674 | $12,256 | 65.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 36 | $5,184 | $3,742 | 72.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 50 | $3,536 | $2,339 | 66.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $4,339 | $2,159 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 107 | $21,117 | $6,515 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 20 | 20 | $4,507 | $2,546 | 56.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 18 | $4,256 | $2,038 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 23 | $3,042 | $763.84 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 273 | $58,695 | $22,038 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 83 | 83 | $19,047 | $10,758 | 56.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 83 | $12,118 | $4,804 | 39.6% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 99 | 99 | $4,104 | $2,047 | 49.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $3,729 | $1,811 | 48.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,168 | $1,316 | 41.6% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 28 | 28 | $1,740 | $853.44 | 49.0% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 26 | 27 | $1,539 | $777.02 | 50.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 30 | $1,200 | $465.72 | 38.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 173 | 249 | $53,535 | $16,758 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 50 | 50 | $11,450 | $5,668 | 49.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 86 | $12,556 | $3,228 | 25.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $2,977 | $1,519 | 51.0% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 23 | 25 | $2,825 | $1,506 | 53.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 35 | 36 | $1,008 | $669.10 | 66.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 26 | 28 | $1,120 | $452.00 | 40.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $1,056 | $269.89 | 25.6% |
About Dr. Sandra Smith, MD
Dr. Sandra Smith, MD is a Family Medicine healthcare provider based in Pahrump, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801912985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Smith, MD has received a total of $893.23 in payments from pharmaceutical and medical device companies, with $37.51 received in 2024. These payments were reported across 62 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($888.23).
As a Medicare-enrolled provider, Smith has provided services to 1,334 Medicare beneficiaries, totaling 1,628 services with total Medicare billing of $107,509. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Pahrump, NV
- Active Since 03/21/2007
- Last Updated 07/05/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801912985
Products in Payments
- OFEV (Drug) $124.72
- BEVESPI AEROSPHERE (Drug) $119.31
- JARDIANCE (Drug) $87.80
- JANUVIA (Drug) $77.38
- Levemir (Drug) $43.12
- FARXIGA (Drug) $38.41
- ASMANEX (Drug) $38.21
- FLEXITOUCH (Device) $28.67
- TRULICITY (Drug) $28.16
- Victoza (Drug) $24.66
- SYMBICORT (Drug) $24.60
- BASAGLAR (Drug) $20.05
- PAXLOVID (Drug) $18.61
- ENTRESTO (Drug) $18.54
- ZURAMPIC (Drug) $17.62
- ADVAIR (Drug) $17.05
- LYRICA (Drug) $15.90
- ImmunoCAP (Device) $13.93
- Cologuard Collection Kit (Device) $13.57
- ANORO (Drug) $12.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pahrump
Matthew Roberson, Md, MD
Family Medicine — Payments: $4,916
Stephen Andracki, Md, MD
Family Medicine — Payments: $2,911
Edward Harding, Md, MD
Family Medicine — Payments: $1,434
Dr. Troy Schumacher, M.d, M.D
Family Medicine — Payments: $1,199
Ola Eisa, M.d, M.D
Family Medicine — Payments: $1,191
Dr. Saira Beg, M.d, M.D
Family Medicine — Payments: $1,011